OR1J2: A Potential Drug Target for Olfactory Disorders (G26740)
OR1J2: A Potential Drug Target for Olfactory Disorders
Olfactory receptor, family 1, subfamily J, member 5 (OR1J2) is a protein that plays a crucial role in the sense of smell. OR1J2 is a G protein-coupled receptor (GPCR), which means it is a transmembrane protein that is composed of an intracellular signaling cascade that involves various intracellular signaling pathways. OR1J2 is expressed in the olfactory epithelium, which are the olfactory epithelial cells lining the nasal cavity.
OR1J2 is an important component of the olfactory system, responsible for sensing odor molecules and transmitting these signals to the brain for olfactory perception. The gene coding region of OR1J2 contains a protein-coding gene that is expressed in humans and other mammals.
In drug development, OR1J2 is considered a potential drug target because it plays an important role in olfactory perception. Some studies have shown that OR1J2 has potential application in drugs to treat olfactory disorders.
OR1J2 is also an important biomarker that can be used to detect and evaluate the effects of drugs on the olfactory system. By measuring the expression levels of OR1J2, researchers can determine whether and how much a drug affects the olfactory system.
Currently, OR1J2 is undergoing intensive research as a drug target. Some researchers are exploring the use of small-molecule drugs to modulate the activity of OR1J2 to treat olfactory disorders. In addition, researchers are also exploring using gene editing technology to change the gene expression levels of OR1J2 to treat specific olfactory disorders.
In summary, OR1J2 is a research object of great significance in drug development and disease treatment. With the deepening of research, OR1J2 will become
Protein Name: Olfactory Receptor Family 1 Subfamily J Member 2
Functions: Odorant receptor
The "OR1J2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR1J2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P
